Skip to main content
Figure 2 | Journal of Hematology & Oncology

Figure 2

From: Novel CD20 monoclonal antibodies for lymphoma therapy

Figure 2

The molecular configuration of CD20 molecule . CD20 is a tetra-transmembrane protein that essentially remains on the membrane of B cells without dissociation or internalization upon antibody binding. The binding sites of CD20 monoclonal antibodies, rituximab and ofatumumab, are indicated.

Back to article page